Nevertheless, ipilimumab has not only provided realistic hope for melanoma patients, especially those with end- stage disease [5], but has initiated a great effort in the search for other immune modulators that can achieve what ipilimumab can, but in a more selective and harm- less fashion, ...
patients clinically significant benefits and the possibility for long-lasting survival at what is normally the terminal stage of the disease. Additionally, the results validate the idea that activating the T cell compartment can, on its own, provide significant therapeutic benefit [5]. Fig. 3 T c...
patients clinically significant benefits and the possibility for long-lasting survival at what is normally the terminal stage of the disease. Additionally, the results validate the idea that activating the T cell compartment can, on its own, provide significant therapeutic benefit [5]. Fig. 3 T c...